The latest closing stock price for Terns Pharmaceuticals as of January 31, 2025 is 4.46.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-757 today, roughly -1 times their original investment - a -29.82% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 155.6% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 4.17, which is 6.5% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 6.84.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-757 today, roughly -1 times their original investment - a -29.82% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 155.6% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 4.17, which is 6.5% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 6.84.